Literature DB >> 16244089

Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis.

P A de Jong1, A Lindblad, L Rubin, W C J Hop, J C de Jongste, M Brink, H A W M Tiddens.   

Abstract

BACKGROUND: A study was undertaken to compare the ability of computed tomographic (CT) scores and pulmonary function tests to detect changes in lung disease in children and adults with cystic fibrosis (CF).
METHODS: CT scans and pulmonary function tests were retrospectively studied in a cohort of patients with CF aged 5-52 years for whom two or three CT scans at 3 year intervals were available, together with pulmonary function test results. All CT scans were scored by two observers. Pulmonary function results were expressed as percentage predicted and Z scores.
RESULTS: Of 119 patients studied, two CT scans were available in 92 patients and three in 24. CT (composite and component) scores and lung function both deteriorated significantly (p<0.02). Peripheral bronchiectasis worsened by 1.7% per year in children (p<0.0001) and by 1.5% per year in adults (p<0.0001). Bronchiectasis worsened in 68 of 92 patients while forced expiratory volume in 1 second (FEV1) worsened in 54 of 92 patients; bronchiectasis also deteriorated in 27 patients with stable or improving FEV1. The CT score (and its components) and pulmonary function tests showed similar rates of deterioration in adults and children (p>0.09).
CONCLUSION: The peripheral bronchiectasis CT score deteriorates faster and more frequently than lung function parameters in children and adults with CF, which indicates that pulmonary function tests and CT scans measure different aspects of CF lung disease. Our data support previous findings that the peripheral bronchiectasis CT score has an added value to pulmonary function tests in monitoring CF lung disease.

Entities:  

Mesh:

Year:  2005        PMID: 16244089      PMCID: PMC2080716          DOI: 10.1136/thx.2005.045146

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  34 in total

Review 1.  The role of inflammation in airway disease: remodeling.

Authors:  H Tiddens; M Silverman; A Bush
Journal:  Am J Respir Crit Care Med       Date:  2000-08       Impact factor: 21.405

2.  An automated approach to quantitative air trapping measurements in mild cystic fibrosis.

Authors:  Michael L Goris; Hongyun J Zhu; Francis Blankenberg; Frandics Chan; Terry E Robinson
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

3.  High resolution CT and bronchography in the assessment of bronchiectasis.

Authors:  K Young; F Aspestrand; A Kolbenstvedt
Journal:  Acta Radiol       Date:  1991-11       Impact factor: 1.990

4.  Cystic fibrosis in children: HRCT findings and distribution of disease.

Authors:  M Maffessanti; M Candusso; F Brizzi; F Piovesana
Journal:  J Thorac Imaging       Date:  1996       Impact factor: 3.000

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Changes in airway dimensions on computed tomography scans of children with cystic fibrosis.

Authors:  Pim A de Jong; Yasutaka Nakano; Wim C Hop; Frederick R Long; Harvey O Coxson; Peter D Paré; Harm A Tiddens
Journal:  Am J Respir Crit Care Med       Date:  2005-04-14       Impact factor: 21.405

7.  Cartilaginous airway wall dimensions and airway resistance in cystic fibrosis lungs.

Authors:  H A Tiddens; L P Koopman; R K Lambert; W M Elliott; W C Hop; T W van der Mark; W J de Boer; J C de Jongste
Journal:  Eur Respir J       Date:  2000-04       Impact factor: 16.671

8.  High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate.

Authors:  A S Brody; P L Molina; J S Klein; B S Rothman; M Ramagopal; D R Swartz
Journal:  Pediatr Radiol       Date:  1999-10

9.  Efficacy of aerosolized tobramycin in patients with cystic fibrosis.

Authors:  B W Ramsey; H L Dorkin; J D Eisenberg; R L Gibson; I R Harwood; R M Kravitz; D V Schidlow; R W Wilmott; S J Astley; M A McBurnie
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

10.  Detecting early structural lung damage in cystic fibrosis.

Authors:  Harm A W M Tiddens
Journal:  Pediatr Pulmonol       Date:  2002-09
View more
  58 in total

1.  Computed tomography dose and variability of airway dimension measurements: how low can we go?

Authors:  Pim A de Jong; Frederick R Long; Yasutaka Nakano
Journal:  Pediatr Radiol       Date:  2006-08-10

Review 2.  Advancing outcome measures for the new era of drug development in cystic fibrosis.

Authors:  Nicole Mayer-Hamblett; Bonnie W Ramsey; Richard A Kronmal
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

Review 3.  Chest imaging in cystic fibrosis studies: What counts, and can be counted?

Authors:  Rhonda Szczesniak; Lidija Turkovic; Eleni-Rosalina Andrinopoulou; Harm A W M Tiddens
Journal:  J Cyst Fibros       Date:  2016-12-28       Impact factor: 5.482

4.  Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis.

Authors:  Don B Sanders; Zhanhai Li; Alan S Brody; Philip M Farrell
Journal:  Am J Respir Crit Care Med       Date:  2011-10-01       Impact factor: 21.405

5.  A semiquantitative MRI-Score can predict loss of lung function in patients with cystic fibrosis: Preliminary results.

Authors:  Juergen F Schaefer; Andreas Hector; Katharina Schmidt; Matthias Teufel; Sabrina Fleischer; Ute Graepler-Mainka; Joachim Riethmueller; Sergios Gatidis; Susanne Schaefer; Konstantin Nikolaou; Dominik Hartl; Ilias Tsiflikas
Journal:  Eur Radiol       Date:  2017-06-29       Impact factor: 5.315

6.  High-resolution CT of nontuberculous mycobacterium infection in adult CF patients: diagnostic accuracy.

Authors:  Sinead McEvoy; Lisa Lavelle; Aoife Kilcoyne; Colin McCarthy; Pim A deJong; Martine Loeve; Harm A W M Tiddens; Edward McKone; Charles G Gallagher; Jonathan D Dodd
Journal:  Eur Radiol       Date:  2012-07-20       Impact factor: 5.315

Review 7.  Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy.

Authors:  Edith T Zemanick; J Kirk Harris; Steven Conway; Michael W Konstan; Bruce Marshall; Alexandra L Quittner; George Retsch-Bogart; Lisa Saiman; Frank J Accurso
Journal:  J Cyst Fibros       Date:  2009-10-14       Impact factor: 5.482

Review 8.  Background and Epidemiology.

Authors:  Don B Sanders; Aliza K Fink
Journal:  Pediatr Clin North Am       Date:  2016-08       Impact factor: 3.278

Review 9.  Computed tomography and cystic fibrosis: promises and problems.

Authors:  Z A Aziz; J C Davies; E W Alton; A U Wells; D M Geddes; D M Hansell
Journal:  Thorax       Date:  2007-02       Impact factor: 9.139

10.  Lung diffusing capacity for nitric oxide and carbon monoxide in relation to morphological changes as assessed by computed tomography in patients with cystic fibrosis.

Authors:  Holger Dressel; Laura Filser; Rainald Fischer; Katharina Marten; Ullrich Müller-Lisse; Dorothea de la Motte; Dennis Nowak; Rudolf M Huber; Rudolf A Jörres
Journal:  BMC Pulm Med       Date:  2009-06-16       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.